Simvastatin and L-arginine preserve renal function after ischemia/reperfusion injury

American Journal of the Medical Sciences

Volumn 329, Issue 1, 2005, Pages 13-17

  Inman, Sharon R ^a,b   Davis, Nancy A ^a   Mazzone, Maria E ^a   Olson, Kristen M ^a   Lukaszek, Victoria A ^a   Yoder, Kristy N ^a  

^a OHIO UNIVERSITY   (United States)

^b OHIO UNIVERSITY   (United States)

Author keywords

Cyclosporine A; HMG CoA reductase inhibitors; Ischemia reperfusion injury; Nitric oxide; Rats

Indexed keywords

ARGININE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IOHEXOL; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRATE REDUCTASE; NITRIC OXIDE; NITRITE; SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEEDING; GLOMERULUS FILTRATION RATE; ISCHEMIA; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; NONHUMAN; RAT; REPERFUSION INJURY;

EID: 11844252132     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200501000-00003     Document Type: Article

References (24)

1. Eggers PW. Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med 1988;318:223-9.
2. Cho YW, Terasaki PI, Cecka JM, et al. Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med 1998;338:221-5.
3. Abraham JS, Bentley FR, Garrison RN, et al. Cyclosporine A directly constricts intrarenal arterioles. Trans Proc 1991;23:356-9.
4. Kocik M, Malek I, Glagolicova A, et al. The effect of cyclosporine A on the level of big endothelin in patients one year after orthotopic heart transplantation. Transpl Int 2004;17:65-70.
5. Auer J, Berent R, Weber T, et al. Clinical significance of pleiotropic effects of statins: lipid reduction and beyond. Current Med Chem 2002;9:1831-50.
6. Laufs U, Gertz K, Dirnagl U, et al. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res 2002;942:23-30.
7. Davignon J, Laaksonen R. Low-density lipoprotein independent effects of statins. Curr Opin Lipidol 1999;10:543-59.
8. Stowe NT, Inman SR, Tapolyai M, et al. Lovastatin has direct renal hemodynamic effects in a rodent model. J Urol 1996;156:249-52.
9. Inman SR, Davis NA, Olson KM, et al. Simvastatin attenuates renal ischemia/reperfusion injury in rats administered cyclosporine A. Am J Med Sci 2003;326:117-21.
10. Buemi M, Senatore M, Corica F, et al. Statins and progressive renal disease. Med Res Rev 2002;22:76-84.
11. Inman SR, Burns TE, Plott WK, et al. Addition of an endothelin antagonist to modified Belzer's perfusion preservation solution mitigates the adverse effect of pre-retrieval warm ischemic injury on post-transplant glomerular filtration rate. Trans Proc 2001;33:2975-6.
12. Inman SR, Burns TE, Plott WK, et al. Endothelin receptor blockade during hypothermic perfusion preservation mitigates the adverse effect of pre-retrieval warm ischemic injury on post-transplant glomerular filtration rate. Transplantation 2002;74:164-8.
13. Lewis RM, Kerr N, Van Buren CT, et al. Comparative evaluation of urographic contrast media, inulin, and 99m Tc-DPTA clearance methods for determination of glomerular filtration rate in clinical transplantation. Transplantation 1989;48:790-6.
14. Lowry OH, Rosebrough NJ, Fall AL, et al. Protein measurement with the oflin phenol reagent. J Biol Chem 1951;193:265-70.
15. Tofovic SP, Kost CK Jr, Jackson EK, et al. Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 (fa-fa (cp)) rats. Kidney Int 2002;61:1433-44.
16. Zar JH. Multicentral hypothesis: the analysis of variance. In: Biostatistical analysis, 2nd ed. Englewood Cliffs (NJ): Prentice Hall; 1984. p. 164.
17. Laufs U, La Fata V, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors. Circulation 1998;97:1129-35.
18. Keasemeyer WH, Caldwell RB, Huang JZ, et al. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol lowering actions. J Am Coll Cardiol 1999;33:234-41.
19. Wheeler DC. Statins and the kidney. Curr Opin Nephrol Hypertens 1998;7:579-84.
20. Gueler F, Rong S, Park J-K, et al. Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 2002;13:2288-98.
21. Chatterjee PK, Patel NSA, Sivarajah A, et al. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental ischemia/reperfusion injury. Kidney Int 2003;63:853-65.
22. Packer MA, Murphy MP. Peroxynitrite formed by simultaneous nitric oxide and superoxide generation causes cyclosporine: a sensitive mitochondrial efflux and depolarization. Eur J Biochem 1995;234:231-9.
23. Yokota N, O'Donnell M, Daniels F, et al. Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol 2003;23:13-7.
24. Cosio FG, Todd, MD, Pesavento TE, et al. Patient survival after renal transplantation III: the effects of statins. Am J Kid Dis 2002;49:638-43.